{"transactions":[{"id":677283,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-08-24T21:21:48.000Z","date":"2026-08-24","kind":"purchase","planned":false,"acquired":true,"shares":53613,"price":10.64,"value":570442.32,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.49 to $10.70. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Genworks 2 Consulting, Inc. (\"Genworks 2\"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein."}],"balance_after":1373397,"source":{"system":"sec-edgar","filing":"0001628280-26-058684","document":"wk-form4_1787606506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828026058684/wk-form4_1787606506.xml","form_type":"4"}},{"id":682686,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-08-18T18:45:24.000Z","date":"2026-08-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.03,"value":110300.0,"ownership":{"direct":true},"balance_after":251000,"source":{"system":"sec-edgar","filing":"0001834423-26-000008","document":"wk-form4_1787078721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442326000008/wk-form4_1787078721.xml","form_type":"4"}},{"id":686454,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-14T16:04:25.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":37200,"price":10.32,"value":383904.0,"ownership":{"direct":true},"balance_after":482800,"source":{"system":"sec-edgar","filing":"0001834411-26-000008","document":"wk-form4_1786723463.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000008/wk-form4_1786723463.xml","form_type":"4"}},{"id":686653,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-08-14T15:50:16.000Z","date":"2026-08-12","kind":"purchase","planned":false,"acquired":true,"shares":46387,"price":10.37,"value":481033.19,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.25 to $10.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Genworks 2 Consulting, Inc. (\"Genworks 2\"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein."}],"balance_after":1319784,"source":{"system":"sec-edgar","filing":"0001628280-26-057007","document":"wk-form4_1786722614.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828026057007/wk-form4_1786722614.xml","form_type":"4"}},{"id":687860,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-08-13T19:01:43.000Z","date":"2026-08-11","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a charitable donation of 50,000 common shares made by Genworks 2 Consulting, Inc. on August 11, 2026."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Genworks 2 Consulting, Inc. The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2 Consulting, Inc. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein."}],"balance_after":1273397,"source":{"system":"sec-edgar","filing":"0001628280-26-056653","document":"wk-form4_1786647701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828026056653/wk-form4_1786647701.xml","form_type":"4"}},{"id":714783,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":19932,"kind":"person","name":"Seely Lynn","position":1,"cik":"0001327111","reported_name":"Seely Lynn","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-07-06T22:20:50.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":152207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":152207,"derivative":{"exercise_price":7.85,"expiration_date":"2036-07-01","underlying":"Common Shares","underlying_shares":152207},"source":{"system":"sec-edgar","filing":"0001628280-26-047400","document":"wk-form4_1783376448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1327111/000162828026047400/wk-form4_1783376448.xml","form_type":"4"}},{"id":714440,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":31980,"kind":"person","name":"Sandor Victor","position":1,"cik":"0001620368","reported_name":"Sandor Victor","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-07-06T22:04:55.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":152207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on July 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":152207,"derivative":{"exercise_price":7.85,"expiration_date":"2036-07-01","underlying":"Common Shares","underlying_shares":152207},"source":{"system":"sec-edgar","filing":"0001628280-26-047396","document":"wk-form4_1783375492.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620368/000162828026047396/wk-form4_1783375492.xml","form_type":"4"}},{"id":739555,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-06-12T17:04:08.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":111701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1011544,"derivative":{"exercise_price":5.27,"exercise_date":"2027-06-10","expiration_date":"2036-06-11","underlying":"Common Shares","underlying_shares":111701},"source":{"system":"sec-edgar","filing":"0001628280-26-042739","document":"wk-form4_1781283845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828026042739/wk-form4_1781283845.xml","form_type":"4"}},{"id":739138,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-06-12T17:02:28.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":111701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1141544,"derivative":{"exercise_price":5.27,"exercise_date":"2027-06-10","expiration_date":"2036-06-11","underlying":"Common Shares","underlying_shares":111701},"source":{"system":"sec-edgar","filing":"0001834423-26-000006","document":"wk-form4_1781283746.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442326000006/wk-form4_1781283746.xml","form_type":"4"}},{"id":740844,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":39076,"kind":"person","name":"Quake Stephen","position":1,"cik":"0001685889","reported_name":"Quake Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2026-06-12T13:03:15.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":111701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2027 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":306633,"derivative":{"exercise_price":5.27,"exercise_date":"2027-06-10","expiration_date":"2036-06-11","underlying":"Common Shares","underlying_shares":111701},"source":{"system":"sec-edgar","filing":"0001685889-26-000002","document":"wk-form4_1781283792.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685889/000168588926000002/wk-form4_1781283792.xml","form_type":"4"}},{"id":750763,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2026-06-03T18:23:16.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8501849,"derivative":{"exercise_price":0.19,"expiration_date":"2026-06-15","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001834411-26-000006","document":"wk-form4_1780510993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000006/wk-form4_1780510993.xml","form_type":"4"}},{"id":750762,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-06-03T18:23:16.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":250000,"price":0.19,"value":47500.0,"ownership":{"direct":true},"balance_after":445600,"source":{"system":"sec-edgar","filing":"0001834411-26-000006","document":"wk-form4_1780510993.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000006/wk-form4_1780510993.xml","form_type":"4"}},{"id":774293,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-05-18T16:09:44.000Z","date":"2026-05-14","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.77,"value":95400.0,"ownership":{"direct":true},"balance_after":241000,"source":{"system":"sec-edgar","filing":"0001834423-26-000004","document":"wk-form4_1779120582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442326000004/wk-form4_1779120582.xml","form_type":"4"}},{"id":873435,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2026-03-02T19:16:40.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":38000,"price":3.44,"value":130720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.42 to $3.45. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":56134097,"source":{"system":"sec-edgar","filing":"0001834449-26-000004","document":"wk-form4_1772478998.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183444926000004/wk-form4_1772478998.xml","form_type":"4"}},{"id":876479,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2026-02-27T21:20:01.000Z","date":"2026-02-26","kind":"purchase","planned":false,"acquired":true,"shares":177457,"price":3.27,"value":580284.39,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $3.19 to $3.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":56096097,"source":{"system":"sec-edgar","filing":"0001834449-26-000002","document":"wk-form4_1772227198.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183444926000002/wk-form4_1772227198.xml","form_type":"4"}},{"id":876478,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-02-27T19:48:34.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":42600,"price":3.42,"value":145692.0,"ownership":{"direct":true},"balance_after":195600,"source":{"system":"sec-edgar","filing":"0001834411-26-000004","document":"wk-form4_1772221711.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000004/wk-form4_1772221711.xml","form_type":"4"}},{"id":949875,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:11:53.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":808898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8751849,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":808898},"source":{"system":"sec-edgar","filing":"0001834411-26-000002","document":"wk-form4_1767633111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441126000002/wk-form4_1767633111.xml","form_type":"4"}},{"id":949874,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:10:55.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":2106505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":13096837,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":2106505},"source":{"system":"sec-edgar","filing":"0001834412-26-000002","document":"wk-form4_1767633053.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441226000002/wk-form4_1767633053.xml","form_type":"4"}},{"id":949873,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:10:22.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":539265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4646012,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":539265},"source":{"system":"sec-edgar","filing":"0001834424-26-000002","document":"wk-form4_1767633019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442426000002/wk-form4_1767633019.xml","form_type":"4"}},{"id":949869,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Share option (right to buy)","published_at":"2026-01-05T17:08:56.000Z","date":"2026-01-01","kind":"grant","planned":false,"acquired":true,"shares":539265,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5201069,"derivative":{"exercise_price":3.42,"expiration_date":"2036-01-01","underlying":"Common Shares","underlying_shares":539265},"source":{"system":"sec-edgar","filing":"0001834418-26-000002","document":"wk-form4_1767632934.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183441826000002/wk-form4_1767632934.xml","form_type":"4"}},{"id":961749,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-12-19T18:24:05.000Z","date":"2025-12-18","kind":"gift","planned":false,"acquired":false,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a charitable donation of 225,000 common shares the reporting person donated on December 18, 2025."}],"balance_after":55918640,"source":{"system":"sec-edgar","filing":"0001834449-25-000004","document":"wk-form4_1766168642.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183444925000004/wk-form4_1766168642.xml","form_type":"4"}},{"id":962627,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":39076,"kind":"person","name":"Quake Stephen","position":1,"cik":"0001685889","reported_name":"Quake Stephen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2025-12-19T14:46:13.000Z","date":"2025-12-01","kind":"grant","planned":false,"acquired":true,"shares":194932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a three-year period, with the first tranche vested on December 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":194932,"derivative":{"exercise_price":3.47,"expiration_date":"2035-12-01","underlying":"Common Shares","underlying_shares":194932},"source":{"system":"sec-edgar","filing":"0001685889-25-000008","document":"wk-form4_1766173569.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685889/000168588925000008/wk-form4_1766173569.xml","form_type":"4"}},{"id":986551,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-26T19:58:20.000Z","date":"2025-11-26","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":3.5692,"value":178460.0,"ownership":{"direct":true},"balance_after":221000,"source":{"system":"sec-edgar","filing":"0001834423-25-000004","document":"wk-form4_1764187098.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000183442325000004/wk-form4_1764187098.xml","form_type":"4"}},{"id":1097719,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2025-07-01T19:13:15.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":238864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":899843,"derivative":{"exercise_price":3.15,"exercise_date":"2026-06-11","expiration_date":"2035-06-12","underlying":"Common Shares","underlying_shares":238864},"source":{"system":"sec-edgar","filing":"0001628280-25-033735","document":"wk-form4_1751397189.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828025033735/wk-form4_1751397189.xml","form_type":"4"}},{"id":1109399,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2025-06-16T21:32:00.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":238864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":1029843,"derivative":{"exercise_price":3.15,"exercise_date":"2026-06-11","expiration_date":"2035-06-12","underlying":"Common Shares","underlying_shares":238864},"source":{"system":"sec-edgar","filing":"0001628280-25-031647","document":"wk-form4_1750109513.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025031647/wk-form4_1750109513.xml","form_type":"4"}},{"id":1109402,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":35667,"kind":"person","name":"Lo Andrew","position":1,"cik":"0001679076","reported_name":"Lo Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2025-06-16T21:30:33.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":238864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable at the 2026 Annual General Meeting, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":541354,"derivative":{"exercise_price":3.15,"exercise_date":"2026-06-11","expiration_date":"2035-06-12","underlying":"Common Shares","underlying_shares":238864},"source":{"system":"sec-edgar","filing":"0001628280-25-031646","document":"wk-form4_1750109427.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679076/000162828025031646/wk-form4_1750109427.xml","form_type":"4"}},{"id":1211501,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2025-03-11T22:42:57.000Z","date":"2025-03-11","kind":"purchase","planned":false,"acquired":true,"shares":343631,"price":2.16,"value":742242.96,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.12 to $2.23. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":56143640,"source":{"system":"sec-edgar","filing":"0001628280-25-012154","document":"wk-form4_1741732971.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025012154/wk-form4_1741732971.xml","form_type":"4"}},{"id":1214422,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-10T21:11:03.000Z","date":"2025-03-10","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":2.3,"value":57500.0,"ownership":{"direct":true},"balance_after":171000,"source":{"system":"sec-edgar","filing":"0001628280-25-011750","document":"wk-form4_1741641056.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025011750/wk-form4_1741641056.xml","form_type":"4"}},{"id":1216813,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-03-07T20:32:01.000Z","date":"2025-03-06","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":2.3428,"value":140568.0,"ownership":{"direct":true},"balance_after":146000,"source":{"system":"sec-edgar","filing":"0001628280-25-011254","document":"wk-form4_1741379514.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025011254/wk-form4_1741379514.xml","form_type":"4"}},{"id":1313309,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:44:41.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":832033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4106747,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":832033},"source":{"system":"sec-edgar","filing":"0001628280-25-000237","document":"wk-form4_1735937075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000237/wk-form4_1735937075.xml","form_type":"4"}},{"id":1313308,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:40:45.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":832033,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":4661804,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":832033},"source":{"system":"sec-edgar","filing":"0001628280-25-000235","document":"wk-form4_1735936840.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000235/wk-form4_1735936840.xml","form_type":"4"}},{"id":1313307,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:37:59.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":1352054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":7942951,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":1352054},"source":{"system":"sec-edgar","filing":"0001628280-25-000233","document":"wk-form4_1735936673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000233/wk-form4_1735936673.xml","form_type":"4"}},{"id":1313306,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2025-01-03T20:36:28.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":2730109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 1, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date"}],"balance_after":10990332,"derivative":{"exercise_price":2.93,"expiration_date":"2035-01-01","underlying":"Common Shares","underlying_shares":2730109},"source":{"system":"sec-edgar","filing":"0001628280-25-000232","document":"wk-form4_1735936582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828025000232/wk-form4_1735936582.xml","form_type":"4"}},{"id":1341285,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-12-05T21:47:21.000Z","date":"2024-12-04","kind":"gift","planned":false,"acquired":false,"shares":286000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a charitable donation of 286,000 common shares the reporting person donated on December 4, 2024."}],"balance_after":55800009,"source":{"system":"sec-edgar","filing":"0001628280-24-050097","document":"wk-form4_1733435235.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024050097/wk-form4_1733435235.xml","form_type":"4"}},{"id":1350525,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-11-26T22:38:20.000Z","date":"2024-11-25","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8260223,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-049327","document":"wk-form4_1732660694.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024049327/wk-form4_1732660694.xml","form_type":"4"}},{"id":1350524,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-11-26T22:38:20.000Z","date":"2024-11-25","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":898000,"source":{"system":"sec-edgar","filing":"0001628280-24-049327","document":"wk-form4_1732660694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024049327/wk-form4_1732660694.xml","form_type":"4"}},{"id":1399876,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-09-24T20:09:35.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8316348,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-041217","document":"wk-form4_1727208568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024041217/wk-form4_1727208568.xml","form_type":"4"}},{"id":1399875,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-09-24T20:09:35.000Z","date":"2024-09-20","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":841875,"source":{"system":"sec-edgar","filing":"0001628280-24-041217","document":"wk-form4_1727208568.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024041217/wk-form4_1727208568.xml","form_type":"4"}},{"id":1419687,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2024-08-29T20:35:34.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":283516,"price":2.61,"value":739976.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $2.55 to $2.67. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":56086009,"source":{"system":"sec-edgar","filing":"0001628280-24-038829","document":"wk-form4_1724963720.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024038829/wk-form4_1724963720.xml","form_type":"4"}},{"id":1470276,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2024-06-24T22:38:32.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":83334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3829771,"derivative":{"exercise_price":0.188,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":83334},"source":{"system":"sec-edgar","filing":"0001628280-24-029675","document":"wk-form4_1719268705.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024029675/wk-form4_1719268705.xml","form_type":"4"}},{"id":1470275,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2024-06-24T22:38:32.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":83334,"price":0.188,"value":15666.792,"ownership":{"direct":true},"balance_after":2123456,"source":{"system":"sec-edgar","filing":"0001628280-24-029675","document":"wk-form4_1719268705.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024029675/wk-form4_1719268705.xml","form_type":"4"}},{"id":1470558,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2024-06-24T22:30:36.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":163934,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":660979,"derivative":{"exercise_price":2.94,"exercise_date":"2025-06-12","expiration_date":"2034-06-21","underlying":"Common Shares","underlying_shares":163934},"source":{"system":"sec-edgar","filing":"0001628280-24-029673","document":"wk-form4_1719268228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000162828024029673/wk-form4_1719268228.xml","form_type":"4"}},{"id":1470288,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":35667,"kind":"person","name":"Lo Andrew","position":1,"cik":"0001679076","reported_name":"Lo Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2024-06-24T22:19:57.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":163934,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":302490,"derivative":{"exercise_price":2.94,"exercise_date":"2025-06-12","expiration_date":"2034-06-21","underlying":"Common Shares","underlying_shares":163934},"source":{"system":"sec-edgar","filing":"0001628280-24-029668","document":"wk-form4_1719267587.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679076/000162828024029668/wk-form4_1719267587.xml","form_type":"4"}},{"id":1470273,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2024-06-24T22:15:19.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":163934,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":790979,"derivative":{"exercise_price":2.94,"exercise_date":"2025-06-12","expiration_date":"2034-06-21","underlying":"Common Shares","underlying_shares":163934},"source":{"system":"sec-edgar","filing":"0001628280-24-029666","document":"wk-form4_1719267313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024029666/wk-form4_1719267313.xml","form_type":"4"}},{"id":1494743,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-06-03T20:21:18.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8372473,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001628280-24-026338","document":"wk-form4_1717446060.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024026338/wk-form4_1717446060.xml","form_type":"4"}},{"id":1494742,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-06-03T20:21:18.000Z","date":"2024-05-31","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":785750,"source":{"system":"sec-edgar","filing":"0001628280-24-026338","document":"wk-form4_1717446060.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000162828024026338/wk-form4_1717446060.xml","form_type":"4"}},{"id":1614506,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-02-27T19:12:58.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8428598,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-24-000026","document":"wk-form4_1709061178.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000026/wk-form4_1709061178.xml","form_type":"4"}},{"id":1614505,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-02-27T19:12:58.000Z","date":"2024-02-26","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":729625,"source":{"system":"sec-edgar","filing":"0001703057-24-000026","document":"wk-form4_1709061178.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000026/wk-form4_1709061178.xml","form_type":"4"}},{"id":1678895,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:23:50.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":770416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3913105,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":770416},"source":{"system":"sec-edgar","filing":"0001703057-24-000008","document":"wk-form4_1705447421.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000008/wk-form4_1705447421.xml","form_type":"4"}},{"id":1678894,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:21:34.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":616333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3274714,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":616333},"source":{"system":"sec-edgar","filing":"0001703057-24-000006","document":"wk-form4_1705447284.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000006/wk-form4_1705447284.xml","form_type":"4"}},{"id":1678893,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:18:59.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":770416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6590897,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":770416},"source":{"system":"sec-edgar","filing":"0001703057-24-000004","document":"wk-form4_1705447127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000004/wk-form4_1705447127.xml","form_type":"4"}},{"id":1678892,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2024-01-16T23:14:23.000Z","date":"2024-01-14","kind":"grant","planned":false,"acquired":true,"shares":2095532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":8484723,"derivative":{"exercise_price":5.39,"expiration_date":"2034-01-14","underlying":"Common Shares","underlying_shares":2095532},"source":{"system":"sec-edgar","filing":"0001703057-24-000002","document":"wk-form4_1705446854.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305724000002/wk-form4_1705446854.xml","form_type":"4"}},{"id":1704149,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2023-12-19T23:08:03.000Z","date":"2023-12-19","kind":"gift","planned":false,"acquired":false,"shares":210000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction represents a charitable donation of 210,000 common shares the reporting person donated on December 19, 2023."}],"balance_after":55802493,"source":{"system":"sec-edgar","filing":"0001703057-23-000049","document":"wk-form4_1703027269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000049/wk-form4_1703027269.xml","form_type":"4"}},{"id":1729338,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-11-27T21:45:10.000Z","date":"2023-11-23","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6389191,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-23-000044","document":"wk-form4_1701121501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000044/wk-form4_1701121501.xml","form_type":"4"}},{"id":1729337,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-11-27T21:45:10.000Z","date":"2023-11-23","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":673500,"source":{"system":"sec-edgar","filing":"0001703057-23-000044","document":"wk-form4_1701121501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000044/wk-form4_1701121501.xml","form_type":"4"}},{"id":1746474,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-08T20:29:53.000Z","date":"2023-11-08","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.46,"value":44600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $4.45 to $4.46. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":86000,"source":{"system":"sec-edgar","filing":"0001703057-23-000042","document":"wk-form4_1699475382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000042/wk-form4_1699475382.xml","form_type":"4"}},{"id":1746473,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-11-08T20:29:53.000Z","date":"2023-11-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.64,"value":92800.0,"ownership":{"direct":true},"balance_after":76000,"source":{"system":"sec-edgar","filing":"0001703057-23-000042","document":"wk-form4_1699475382.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000042/wk-form4_1699475382.xml","form_type":"4"}},{"id":1773241,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-09-26T16:26:07.000Z","date":"2023-09-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.91,"value":98200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $4.89 to $4.93. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Genworks 2 Consulting, Inc. (\"Genworks 2\"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein."}],"balance_after":1323397,"source":{"system":"sec-edgar","filing":"0001703057-23-000032","document":"wk-form4_1695745559.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000170305723000032/wk-form4_1695745559.xml","form_type":"4"}},{"id":1780767,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2023-09-14T20:38:44.000Z","date":"2023-09-12","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":5.19,"value":103800.0,"ownership":{"direct":true},"balance_after":2040122,"source":{"system":"sec-edgar","filing":"0001703057-23-000030","document":"wk-form4_1694723915.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000030/wk-form4_1694723915.xml","form_type":"4"}},{"id":1795986,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-08-25T17:57:14.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6445316,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-27","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001703057-23-000027","document":"wk-form4_1692986225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000027/wk-form4_1692986225.xml","form_type":"4"}},{"id":1795985,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-08-25T17:57:14.000Z","date":"2023-08-24","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":617375,"source":{"system":"sec-edgar","filing":"0001703057-23-000027","document":"wk-form4_1692986225.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000170305723000027/wk-form4_1692986225.xml","form_type":"4"}},{"id":1811883,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2023-08-09T16:22:00.000Z","date":"2023-08-08","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":5.9,"value":177000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $5.89 to $5.91. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These shares are held by Genworks 2 Consulting, Inc. (\"Genworks 2\"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein."}],"balance_after":1303397,"source":{"system":"sec-edgar","filing":"0001703057-23-000024","document":"wk-form4_1691598110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000170305723000024/wk-form4_1691598110.xml","form_type":"4"}},{"id":1874221,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-05-30T17:14:36.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6501441,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-23-032793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032793/doc4.xml","form_type":"4"}},{"id":1874220,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-05-30T17:14:36.000Z","date":"2023-05-26","kind":"exercise","planned":false,"acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":561250,"source":{"system":"sec-edgar","filing":"0001209191-23-032793","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032793/doc4.xml","form_type":"4"}},{"id":1875842,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-05-26T18:53:34.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":14500,"price":6.85,"value":99325.0,"ownership":{"direct":true},"balance_after":153000,"source":{"system":"sec-edgar","filing":"0001209191-23-032484","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032484/doc4.xml","form_type":"4"}},{"id":1875841,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2023-05-26T18:50:26.000Z","date":"2023-05-26","kind":"purchase","planned":false,"acquired":true,"shares":153000,"price":6.5211,"value":997728.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.39 to $6.90. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":56012493,"source":{"system":"sec-edgar","filing":"0001209191-23-032481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123032481/doc4.xml","form_type":"4"}},{"id":1899156,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share option (right to buy)","published_at":"2023-05-09T19:02:28.000Z","date":"2023-05-05","kind":"exercise","planned":false,"acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on November 8, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3142689,"derivative":{"exercise_price":0.19,"expiration_date":"2027-03-23","underlying":"Common Shares","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-23-028214","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123028214/doc4.xml","form_type":"4"}},{"id":1899155,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2023-05-09T19:02:28.000Z","date":"2023-05-05","kind":"exercise","planned":false,"acquired":true,"shares":250000,"price":0.19,"value":47500.0,"ownership":{"direct":true},"balance_after":2020122,"source":{"system":"sec-edgar","filing":"0001209191-23-028214","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123028214/doc4.xml","form_type":"4"}},{"id":1995198,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2023-02-23T21:33:24.000Z","date":"2023-02-22","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6557566,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-23-012199","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123012199/doc4.xml","form_type":"4"}},{"id":1995197,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-02-23T21:33:24.000Z","date":"2023-02-22","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":505125,"source":{"system":"sec-edgar","filing":"0001209191-23-012199","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919123012199/doc4.xml","form_type":"4"}},{"id":2077345,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share option (right to buy)","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable annually in substantially equal installments over a six-year period, with the first tranche vested on June 15, 2017, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5820481,"derivative":{"exercise_price":0.19,"expiration_date":"2026-06-15","underlying":"Common shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2077344,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common shares","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"gift","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a charitable donation of 50,000 common shares the reporting person donated on December 20, 2022."}],"balance_after":138500,"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2077343,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-12-22T19:31:23.000Z","date":"2022-12-20","kind":"exercise","acquired":true,"shares":50000,"price":0.19,"value":9500.0,"ownership":{"direct":true},"balance_after":188500,"source":{"system":"sec-edgar","filing":"0001209191-22-062412","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062412/doc4.xml","form_type":"4"}},{"id":2079387,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-12-20T15:18:00.000Z","date":"2022-12-16","kind":"purchase","acquired":true,"shares":85102,"price":10.0967,"value":859249.3634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $10.04 to $10.15. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55859493,"source":{"system":"sec-edgar","filing":"0001209191-22-062090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122062090/doc4.xml","form_type":"4"}},{"id":2095501,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":35667,"kind":"person","name":"Lo Andrew","position":1,"cik":"0001679076","reported_name":"Lo Andrew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-12-05T17:34:41.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":47231,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":138556,"derivative":{"exercise_price":13.18,"exercise_date":"2024-06-15","expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":47231},"source":{"system":"sec-edgar","filing":"0001209191-22-059580","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1679076/000120919122059580/doc4.xml","form_type":"4"}},{"id":2095897,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":20312,"kind":"person","name":"Hayden Michael R","position":1,"cik":"0001352908","reported_name":"Hayden Michael R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (right to buy)","published_at":"2022-12-05T17:33:10.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":47231,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":497045,"derivative":{"exercise_price":13.18,"exercise_date":"2024-06-15","expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":47231},"source":{"system":"sec-edgar","filing":"0001209191-22-059579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1352908/000120919122059579/doc4.xml","form_type":"4"}},{"id":2095497,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share option (right to buy)","published_at":"2022-12-05T17:30:43.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":47231,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":627045,"derivative":{"exercise_price":13.18,"exercise_date":"2024-06-15","expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":47231},"source":{"system":"sec-edgar","filing":"0001209191-22-059578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059578/doc4.xml","form_type":"4"}},{"id":2095496,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:28:50.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":462535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":3392689,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":462535},"source":{"system":"sec-edgar","filing":"0001209191-22-059573","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059573/doc4.xml","form_type":"4"}},{"id":2095495,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70243,"kind":"person","name":"Stimart Tryn","position":1,"cik":"0001834424","reported_name":"Stimart Tryn","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:22:32.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":346901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":2658381,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":346901},"source":{"system":"sec-edgar","filing":"0001209191-22-059570","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059570/doc4.xml","form_type":"4"}},{"id":2095494,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:19:52.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":485661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first\ntranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5870481,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":485661},"source":{"system":"sec-edgar","filing":"0001209191-22-059568","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059568/doc4.xml","form_type":"4"}},{"id":2095493,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share Options (right to buy)","published_at":"2022-12-05T17:13:30.000Z","date":"2022-12-01","kind":"grant","acquired":true,"shares":925069,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on December 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":6613691,"derivative":{"exercise_price":13.18,"expiration_date":"2032-12-01","underlying":"Common Shares","underlying_shares":925069},"source":{"system":"sec-edgar","filing":"0001209191-22-059566","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122059566/doc4.xml","form_type":"4"}},{"id":2108173,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-11-22T02:36:15.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5688622,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-058300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122058300/doc4.xml","form_type":"4"}},{"id":2108172,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-11-22T02:36:15.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":449000,"source":{"system":"sec-edgar","filing":"0001209191-22-058300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122058300/doc4.xml","form_type":"4"}},{"id":2120819,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-11-10T00:31:44.000Z","date":"2022-10-31","kind":"gift","acquired":false,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a chartiable donation of 70,000 common shares the reporting person donated on October 31, 2022."}],"balance_after":55774391,"source":{"system":"sec-edgar","filing":"0001209191-22-056271","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122056271/doc4.xml","form_type":"4"}},{"id":2176672,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-08-22T19:27:38.000Z","date":"2022-08-19","kind":"purchase","acquired":true,"shares":200000,"price":11.4623,"value":2292460.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $11.20 to $11.59. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55844391,"source":{"system":"sec-edgar","filing":"0001209191-22-046998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122046998/doc4.xml","form_type":"4"}},{"id":2176671,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-08-22T19:09:12.000Z","date":"2022-08-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5744747,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-046995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122046995/doc4.xml","form_type":"4"}},{"id":2176670,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-08-22T19:09:12.000Z","date":"2022-08-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":392875,"source":{"system":"sec-edgar","filing":"0001209191-22-046995","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122046995/doc4.xml","form_type":"4"}},{"id":2231043,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-15T17:14:45.000Z","date":"2022-06-14","kind":"purchase","acquired":true,"shares":9173,"price":8.0499,"value":73841.7327,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $8.045 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55644391,"source":{"system":"sec-edgar","filing":"0001209191-22-036884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122036884/doc4.xml","form_type":"4"}},{"id":2231042,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-15T17:14:45.000Z","date":"2022-06-13","kind":"purchase","acquired":true,"shares":54915,"price":8.0318,"value":441066.297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.99 to $8.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55635218,"source":{"system":"sec-edgar","filing":"0001209191-22-036884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122036884/doc4.xml","form_type":"4"}},{"id":2238651,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-06-08T19:32:53.000Z","date":"2022-06-06","kind":"purchase","acquired":true,"shares":64545,"price":7.4981,"value":483964.8645,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $7.44 to $7.55. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55580303,"source":{"system":"sec-edgar","filing":"0001209191-22-034983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122034983/doc4.xml","form_type":"4"}},{"id":2263071,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-05-19T17:17:38.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5800872,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-030394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122030394/doc4.xml","form_type":"4"}},{"id":2263070,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-05-19T17:17:38.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":56125,"price":2.7,"value":151537.5,"ownership":{"direct":true},"balance_after":336750,"source":{"system":"sec-edgar","filing":"0001209191-22-030394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122030394/doc4.xml","form_type":"4"}},{"id":2267290,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-05-17T19:07:35.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":200000,"price":6.3389,"value":1267780.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.22 to $6.50. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":1770122,"source":{"system":"sec-edgar","filing":"0001209191-22-029542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029542/doc4.xml","form_type":"4"}},{"id":2267288,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-05-17T19:04:45.000Z","date":"2022-05-13","kind":"purchase","acquired":true,"shares":300000,"price":7.2551,"value":2176530.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $6.88 to $7.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55515758,"source":{"system":"sec-edgar","filing":"0001209191-22-029541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029541/doc4.xml","form_type":"4"}},{"id":2269745,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":63869,"kind":"organization","name":"Thermopylae Holdings Ltd.","position":1,"cik":"0001834449","reported_name":"Thermopylae Holdings Ltd.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares","published_at":"2022-05-16T18:14:55.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":1408468,"price":6.4054,"value":9021800.9272,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were acquired in multiple transactions at prices ranging from $5.44 to $6.78. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote."}],"balance_after":55215758,"source":{"system":"sec-edgar","filing":"0001209191-22-029092","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029092/doc4.xml","form_type":"4"}},{"id":2269744,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":23221,"kind":"person","name":"Booth Andrew","position":1,"cik":"0001834411","reported_name":"Booth Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2022-05-16T18:13:24.000Z","date":"2022-05-12","kind":"purchase","acquired":true,"shares":85000,"price":5.79,"value":492150.0,"ownership":{"direct":true},"balance_after":138500,"source":{"system":"sec-edgar","filing":"0001209191-22-029091","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122029091/doc4.xml","form_type":"4"}},{"id":2349465,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-04T21:51:53.000Z","date":"2022-03-04","kind":"purchase","acquired":true,"shares":10000,"price":8.54,"value":85400.0,"ownership":{"direct":true},"balance_after":56000,"source":{"system":"sec-edgar","filing":"0001209191-22-016327","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122016327/doc4.xml","form_type":"4"}},{"id":2352438,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":22024,"kind":"person","name":"Montalbano John S.","position":1,"cik":"0001834423","reported_name":"Montalbano John S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2022-03-03T17:06:01.000Z","date":"2022-03-01","kind":"purchase","acquired":true,"shares":20000,"price":9.05,"value":181000.0,"ownership":{"direct":true},"balance_after":46000,"source":{"system":"sec-edgar","filing":"0001209191-22-015227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122015227/doc4.xml","form_type":"4"}},{"id":2364247,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70241,"kind":"person","name":"Lecault Veronique","position":1,"cik":"0001834418","reported_name":"Lecault Veronique","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Shares","published_at":"2022-03-02T00:49:14.000Z","date":"2022-02-28","kind":"purchase","acquired":true,"shares":230789,"price":8.66,"value":1998632.74,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased at prices ranging from $8.48 to $8.80. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information\nregarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":1570122,"source":{"system":"sec-edgar","filing":"0001209191-22-014395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122014395/doc4.xml","form_type":"4"}},{"id":2371374,"issuer":{"id":4118,"kind":"organization","name":"AbCellera Biologics Inc."},"owners":[{"id":70244,"kind":"person","name":"Hansen Carl L. G.","position":1,"cik":"0001834412","reported_name":"Hansen Carl L. G.","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Share option (right to buy)","published_at":"2022-02-25T18:50:48.000Z","date":"2022-02-22","kind":"exercise","acquired":false,"shares":56125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to such option vest and become exercisable quarterly in substantially equal installments over a four-year period, with the first tranche vested on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":5856997,"derivative":{"exercise_price":2.7,"expiration_date":"2030-11-18","underlying":"Common Shares","underlying_shares":56125},"source":{"system":"sec-edgar","filing":"0001209191-22-013012","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1703057/000120919122013012/doc4.xml","form_type":"4"}}],"next_cursor":"2022-02-25T18:50:48.000000Z,2371374"}